X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (53523) 53523
Newsletter (1228) 1228
Magazine Article (99) 99
Newspaper Article (41) 41
Dissertation (32) 32
Book Chapter (31) 31
Publication (20) 20
Conference Proceeding (11) 11
Book Review (10) 10
Reference (6) 6
Book / eBook (5) 5
Web Resource (4) 4
Government Document (2) 2
Streaming Video (2) 2
Journal / eJournal (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (41359) 41359
female (26597) 26597
male (22362) 22362
middle aged (22114) 22114
fluorouracil - administration & dosage (21657) 21657
oncology (20602) 20602
aged (19236) 19236
fluorouracil (18805) 18805
antineoplastic combined chemotherapy protocols - therapeutic use (17174) 17174
adult (15986) 15986
chemotherapy (14257) 14257
cancer (11848) 11848
fluorouracil - therapeutic use (11116) 11116
5-fluorouracil (9182) 9182
treatment outcome (8467) 8467
animals (7796) 7796
fluorouracil - adverse effects (6420) 6420
fluorouracil - pharmacology (6277) 6277
colorectal cancer (6142) 6142
combined modality therapy (6108) 6108
antineoplastic combined chemotherapy protocols - adverse effects (6104) 6104
colorectal neoplasms - drug therapy (5950) 5950
cisplatin - administration & dosage (5663) 5663
neoplasm staging (5281) 5281
leucovorin (5263) 5263
prognosis (5226) 5226
surgery (5127) 5127
aged, 80 and over (5102) 5102
breast neoplasms - drug therapy (4967) 4967
leucovorin - administration & dosage (4844) 4844
antineoplastic combined chemotherapy protocols - administration & dosage (4675) 4675
chemotherapy, adjuvant (4630) 4630
care and treatment (4523) 4523
carcinoma (4510) 4510
mice (4501) 4501
drug administration schedule (4452) 4452
oxaliplatin (4452) 4452
deoxycytidine - analogs & derivatives (4417) 4417
research (4386) 4386
therapy (4369) 4369
colorectal neoplasms - pathology (4315) 4315
capecitabine (4304) 4304
adenocarcinoma - drug therapy (4299) 4299
survival rate (4278) 4278
disease-free survival (4114) 4114
fluorouracil - analogs & derivatives (4070) 4070
survival (4016) 4016
pharmacology & pharmacy (3946) 3946
retrospective studies (3919) 3919
cisplatin (3866) 3866
antineoplastic agents - therapeutic use (3694) 3694
survival analysis (3503) 3503
radiotherapy (3497) 3497
follow-up studies (3391) 3391
neoplasm metastasis (3297) 3297
metastasis (3250) 3250
stomach neoplasms - drug therapy (3250) 3250
liver neoplasms - secondary (3190) 3190
organoplatinum compounds - administration & dosage (3173) 3173
time factors (3115) 3115
antimetabolites, antineoplastic - therapeutic use (3076) 3076
analysis (3072) 3072
medicine & public health (3070) 3070
liver neoplasms - drug therapy (3068) 3068
camptothecin - analogs & derivatives (3067) 3067
trial (3067) 3067
cyclophosphamide - administration & dosage (2991) 2991
colonic neoplasms - drug therapy (2932) 2932
deoxycytidine - administration & dosage (2847) 2847
antimetabolites, antineoplastic - administration & dosage (2831) 2831
irinotecan (2696) 2696
cell line, tumor (2632) 2632
carcinoma, squamous cell - drug therapy (2579) 2579
antineoplastic agents - administration & dosage (2518) 2518
prospective studies (2489) 2489
dose-response relationship, drug (2464) 2464
methotrexate - administration & dosage (2429) 2429
breast cancer (2419) 2419
drug therapy, combination (2362) 2362
doxorubicin - administration & dosage (2312) 2312
bevacizumab (2275) 2275
tumors (2260) 2260
breast neoplasms - pathology (2257) 2257
colorectal-cancer (2207) 2207
1st-line treatment (2183) 2183
camptothecin - administration & dosage (2151) 2151
health aspects (2149) 2149
apoptosis (2137) 2137
drug therapy (2125) 2125
combination (2063) 2063
expression (2063) 2063
lymphatic metastasis (2058) 2058
adenocarcinoma - pathology (2016) 2016
adjuvant chemotherapy (2006) 2006
infusions, intravenous (2006) 2006
adenocarcinoma (2001) 2001
gastroenterology & hepatology (1985) 1985
antineoplastic agents - pharmacology (1976) 1976
randomized-trial (1954) 1954
stomach neoplasms - pathology (1921) 1921
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (48968) 48968
Japanese (3679) 3679
German (1092) 1092
French (987) 987
Chinese (786) 786
Russian (615) 615
Italian (295) 295
Spanish (214) 214
Polish (100) 100
Korean (78) 78
Portuguese (62) 62
Hungarian (42) 42
Dutch (33) 33
Czech (29) 29
Danish (29) 29
Hebrew (22) 22
Norwegian (22) 22
Romanian (13) 13
Swedish (13) 13
Ukrainian (13) 13
Slovak (11) 11
Turkish (11) 11
Bulgarian (10) 10
Croatian (6) 6
Serbian (6) 6
Finnish (5) 5
Lithuanian (5) 5
Arabic (3) 3
Afrikaans (1) 1
Icelandic (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 2014, Volume 371, Issue 17, pp. 1609 - 1618
In patients with metastatic colon cancer, fluorouracil, oxaliplatin, and irinotecan plus bevacizumab, as compared with fluorouracil and irinotecan plus... 
1ST-LINE TREATMENT | MEDICINE, GENERAL & INTERNAL | INFUSIONAL FLUOROURACIL | LEUCOVORIN | MANAGEMENT | PHASE-III | GUIDELINES | IRINOTECAN | OXALIPLATIN | CHEMOTHERAPY | FOLFIRI | Follow-Up Studies | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Bevacizumab | Fluorouracil - therapeutic use | Antibodies, Monoclonal, Humanized - administration & dosage | Leucovorin - adverse effects | Fluorouracil - adverse effects | Neoplasm Metastasis - drug therapy | Colorectal Neoplasms - drug therapy | Adult | Female | Leucovorin - therapeutic use | Liver Neoplasms - secondary | Camptothecin - analogs & derivatives | Colorectal Neoplasms - mortality | Antibodies, Monoclonal, Humanized - adverse effects | Camptothecin - adverse effects | Camptothecin - therapeutic use | Kaplan-Meier Estimate | Liver Neoplasms - drug therapy | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Colorectal Neoplasms - pathology | Organoplatinum Compounds - therapeutic use | Organoplatinum Compounds - adverse effects | Treatment outcome | Care and treatment | Analysis | Colorectal cancer | Dosage and administration | Leucovorin | Fluorouracil | Colorectal carcinoma | Diarrhea | Metastasis | Survival | Patients | Clinical outcomes | Metastases | Irinotecan | Stomatitis | Chemotherapy | Neurotoxicity | Oxaliplatin | Monoclonal antibodies | Vascular endothelial growth factor | Neutropenia | Index Medicus | Abridged Index Medicus
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 2007, Volume 25, Issue 33, pp. 5210 - 5217
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2015, Volume 385, Issue 9980, pp. 1843 - 1852
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 2008, Volume 26, Issue 12, pp. 2013 - 2019
Journal Article
Clinical pharmacology and therapeutics, ISSN 0009-9236, 2018, Volume 103, Issue 2, pp. 210 - 216
Journal Article
The lancet oncology, ISSN 1470-2045, 2010, Volume 11, Issue 9, pp. 853 - 860
Summary Background Fluorouracil and folinic acid with either oxaliplatin (FOLFOX) or irinotecan (FOLFIRI) are widely used as first-line or second-line... 
Hematology, Oncology and Palliative Medicine | TRIAL | CAPECITABINE | 1ST-LINE TREATMENT | INFUSIONAL FLUOROURACIL/LEUCOVORIN | LEUCOVORIN | THERAPY | ONCOLOGY | 5-FLUOROURACIL/FOLINIC ACID | FLUOROPYRIMIDINE | OXALIPLATIN | FAILURE | Prodrugs - administration & dosage | Leucovorin - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Organoplatinum Compounds - administration & dosage | Fluorouracil - administration & dosage | Leucovorin - adverse effects | Fluorouracil - adverse effects | Colorectal Neoplasms - drug therapy | Adult | Camptothecin - administration & dosage | Female | Camptothecin - analogs & derivatives | Colorectal Neoplasms - mortality | Camptothecin - adverse effects | Fluorouracil - analogs & derivatives | Tegafur - adverse effects | Kaplan-Meier Estimate | Oxonic Acid - administration & dosage | Adenocarcinoma - drug therapy | Oxonic Acid - adverse effects | Disease-Free Survival | Prodrugs - adverse effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Tegafur - administration & dosage | Aged | Drug Combinations | Adenocarcinoma - mortality | Medical colleges | Chemotherapy | Oncology, Experimental | Colorectal cancer | Leucovorin | Research | Metastasis | Cancer | Fluorouracil | Analysis
Journal Article
JNCI : Journal of the National Cancer Institute, ISSN 1460-2105, 2015, Volume 107, Issue 11, p. djv248
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 2009, Volume 27, Issue 33, pp. 5513 - 5518
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 2010, Volume 28, Issue 19, pp. 3191 - 3198
Journal Article